Optimal Approach to Accurate Early Diagnosis and Management of Parkinson's Disease
Thursday, June 25, 2009 1:00 PM - 2:00 PM ET

Description and Intended Audience:

This segment features Dr. Andrew Siderowf focusing on Early Diagnosis and Treatment of Parkinson's Disease. This activity is intended for neurologists, pharmacists, and other medical professionals with a specific interest in the management of Parkinson's disease.

Learning Objectives:

Upon completion of this Teleconference, participants should be able to:

Become familiar with rapidly evolving genetic risk information for Parkinson's disease
Recognize non-motor aspects of PD and their relationship to diagnosis and disease progression
Understand current approach to initial treatment to early PD
Identify appropriate candidates and typical outcomes for deep brain stimulation surgery as treatment for PD

Speaker Information and Disclosures:

Andrew Siderowf, MD
The University of Pennsylvania
Associate Professor of Neurology
Philadelphia, PA

Andrew Siderowf, MD, is an Associate Professor of Neurology at the University of Pennsylvania Health System. Dr. Siderowf received his BA degree from Yale University and his medical degree from the Duke University School of Medicine in Durham, North Carolina. He completed residency in Neurology at the University of Pennsylvania. After a 2-year fellowship in experimental therapeutics (movement disorders) at Strong Memorial Hospital in Rochester, New York, Dr. Siderowf returned to Philadelphia to practice.

Dr. Siderowf is a member of the American Academy of Neurology (AAN), the Movement Disorders Society (MDS), and the Parkinson Study Group (PSG). He is medical director of the National Parkinson Foundation Center of Excellence at Pennsylvania Hospital.

Recognized as an expert on Parkinson’s Disease (PD) and movement disorders, Dr. Siderowf is the author of more than 70 peer-reviewed/invited articles and editorials on these and related subjects. His areas of interest include clinical trial design, cognitive impairment, and neuropsychiatric syndromes in neurodegenerative diseases. He has receives funding from the National Institutes of Health.

Disclosure: No relevant financial relationships to disclose.

CE Information:

Physicians:

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Cine-Med and Astute Technology. Cine-Med is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Cine-Med, Inc. designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Pharmacists:

Cine-Med is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is accredited for 0.1 CEU (1.0 contact hour) of continuing education credit. ACPE Universal Number 0399-999-09-010-H01-P. Activity type: knowledge-based.

How to get CE credit:

To receive credit, participants must view the webcast, register on this site, and successfully complete the post-test and evaluation (successful passing grade >=70%). Certificates can be printed on line.